Arkolith/Insider Trading/CDMO/Form 4

Ziebell Mark R

V. P., General CounselAvid Bioservices, Inc. (CDMO) · full profile →Form 4 · filed Feb 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2025Disposed to issuer(D)67K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 5, 2025Disposed to issuer(D)21K——153K
Feb 5, 2025Disposed to issuer(D)98K——55K
Feb 5, 2025Disposed to issuer(D)55K——0
Feb 5, 2025Disposed to issuer(D)18K——51K
Feb 5, 2025Disposed to issuer(D)2K——109K
Feb 5, 2025Disposed to issuer(D)109K——0
Feb 5, 2025Disposed to issuer(D)14K——175K
Feb 5, 2025Disposed to issuer(D)51K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-25-000864) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML